key: cord-1052482-w4o675sc
authors: Borges, V.; Isidro, J.; Trovao, N. S.; Duarte, S.; Cortes-Martins, H.; Martiniano, H.; Gordo, I.; Leite, R.; Vieira, L.; Portuguese network for SARS-CoV-2 genomics,; Guiomar, R.; Gomes, J. P.
title: The early dynamics of the SARS-CoV-2 epidemic in Portugal
date: 2021-02-23
journal: nan
DOI: 10.1101/2021.02.22.21252216
sha: 92d256e5cfc6921d1e3af183422d409bab3d2488
doc_id: 1052482
cord_uid: w4o675sc

Background: Genomic surveillance of SARS-CoV-2 in Portugal was rapidly implemented by the National Institute of Health in the early stages of the COVID-19 epidemic, in collaboration with more than 50 laboratories distributed nationwide. This unprecedented collaborative effort culminated in the generation of 1275 SARS-CoV-2 genome sequences, which represent 15.5% of all confirmed cases in March 2020, making Portugal one of the countries generating the highest volumes of SARS-CoV-2 genomic data during early COVID-19 pandemic. Methods: We reconstructed and characterized the spatio-temporal dynamics of SARS-CoV-2 introductions and early dissemination in Portugal using recent phylodynamic models that allow integration of individual-based travel history, in order to obtain a more realistic reconstruction of the viral dynamics. Results: We detected at least 277 independent SARS-CoV-2 introductions, mostly from European countries (namely the United Kingdom, Spain, France, Italy and Switzerland), which was broadly consistent with the available travel history data, as well as with the countries with most frequent connectivity and/or with the highest number of Portuguese immigrants. Although most introductions were estimated to have occurred during the last week of February and the first week of March 2020, it is likely that SARS-CoV-2 was silently circulating in Portugal several weeks before the first confirmed local cases on March 2, 2020. Discussion and Conclusion: While the implemented preventive and early control measures seem to have been successful in mitigating community transmission from most independent introductions, our results suggest that their earlier implementation could have largely minimized the number of introductions and subsequent virus expansion. Here we lay the foundation for genomic epidemiology of SARS-CoV-2 in Portugal, and highlight the need for systematic, continuous and geographically-representative genomic surveillance to guide national and international public health authorities toward the characterization and control of SARS-CoV-2 circulating diversity.

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), the causative agent of COVID-19, is a novel betacoronavirus that was first reported in December 2019 in Wuhan, China (Zhou et al, 2020; Wu et al, 2020) . It was declared a global public health emergency that, as of February 17, 2020, has caused more than 109 million cases and two million deaths worldwide (WHO, 2021; Dong et al, 2020) . In order to control the virus arrival and spread, many countries adopted rigid public health measures, including complete border closures and general lockdowns, with tremendous consequences at economic and social levels. At the early stages of an epidemic, the success of public health measures is particularly dependent on their timely implementation, which requires comprehensive diagnosis/surveillance systems that are able to efficiently trace where the virus is being introduced and circulating characterizing the genetic variability that may negatively affect molecular diagnostic tests; iv) identifying and monitoring genetic variability affecting antigens and targets of antiviral drugs with potential impact on the development/effectiveness of prophylactic (vaccines) and therapeutic measures; v) investigating potential associations between genetic variants and infectious load, patient immunological status, clinical outcomes (e.g., infection duration, disease severity, etc) (Alm et al, 2020) . Acting as the National Reference Laboratory for SARS-CoV-2, the Portuguese National Institute of Health (INSA) Doutor Ricardo Jorge rapidly established a genome-based molecular surveillance strategy for SARS-CoV-2 in Portugal, setting up a large nationwide network involving more than 50 laboratories. A website (https://insaflu.insa.pt/covid19) was launched, providing updated data regarding the analysis of the SARS-CoV-2 genetic diversity and geotemporal dynamics. Also, "situation reports" with major highlights are being released periodically to participating laboratories, national and regional public health authorities and other stakeholders. Despite all the advantages of genomic surveillance, the uneven geographic sampling of viral genomes can severely skew . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 phylogeographic inferences based on discrete trait ancestral reconstruction (Lemey et al, 2020) , therefore hindering the ability to accurately trace the seeding and dissemination patterns of SARS-CoV-2. The COVID-19 pandemic has been characterized by an unprecedented amount of genomic data and associated metadata, such as information on the patients' recent movements prior to having developed any symptoms.

In the present study, we reconstruct and characterize the spatio-temporal dynamics of SARS-CoV-2 introductions and early dissemination in Portugal using newly developed phylodynamic models that allow integration of individual-based travel history, in order to obtain a more realistic reconstruction of the viral dynamics (Lemey et al, 2020) . This includes inferences of the timeliness of the very first introductions, geographic location of ancestral lineages and the contribution of detected introductions on the epidemic evolution.

Samples used in this study were collected as part of the ongoing national SARS-CoV-2 laboratory surveillance conducted by the National Institute of Health (INSA) Doutor Ricardo Jorge, Portugal. SARS-CoV-2 positive samples (either clinical specimens or RNA) were provided by a nationwide network, consisting of more than 50 laboratories, that was established at the beginning of the epidemic in Portugal. Anonymized date of sample collection, date of illness onset and travel history were provided by laboratories and Regional and National Health Authorities. Geographical data presented in this study refers to the Region ("Health Administration region") the patients' residence or, when no information is available (for a small proportion of cases), to the Region of exposure or of the hospital/laboratory that collected/sent the sample.

SARS-CoV-2 positive RNA samples were subjected to genome sequencing using a wholegenome amplification strategy with tiled, multiplexed primers (Quick et al, 2017) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

Analysis of sequence read data was conducted using the bioinformatics pipeline implemented in INSaFLU (https://insaflu.insa.pt/; https://github.com/INSaFLU), which is a web-based (and also locally installable) platform for amplicon-based next-generation sequencing data analysis (Borges et al, 2018 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10. 1101 100bp were discarded and consensus sequences were exclusively included in the study when >70% of the genome was covered by at least 10-fold. For samples with coverage drop below 10-fold, fine-tuned consensus sequence curation was performed as follows: i) undefined bases ("N") were placed in genome regions with depth of coverage below 10 using a python script (https://github.com/rfm-targa/BioinfUtils/blob/master/msa_masker.py), and "N" regions at the sequence ends were trimmed to avoid releasing sequences starting or ending with "N";

ii) all regions with depth coverage below 10 were visually inspected in the Integrative Genomics Viewer (http://www.broadinstitute.org/igv) available in situ at INSaFLU, and when mutations were detected and validated within these low coverage regions, they were inserted in the consensus sequence to avoid disrupting/biasing the phylogenetic signal; iii) when a mutation was validated within a "N" region with <=100bp, the whole region was inserted (as long as the region was covered by at least one read); when a mutation was validated within a "N" region with >100bp, the mutation was inserted together with additional 20bp (10bp from each flanking side) to improve the downstream sequence alignment.

We explored the diversity of INSA sequences using a variety of nomenclature strategies, namely Nextstrain (using https://clades.nextstrain.org/; 9 November 2020), GISAID (https://www.gisaid.org/; 23 July 2020) and Phylogenetic Assignment of Named Global Outbreak LINeages (cov-lineages.org) (https://pangolin.cog-uk.io/; 16 October 2020) . While Nextstrain and GISAID clade nomenclatures provide a less detailed categorisation of globally circulating diversity, cov-lineages.org classification is focused on identifying highly specific lineages that are actively transmitting in the population . Classification is provided in Supplementary material ( Table S1 ).

To assess the contribution of each country to the set of publicly available SARS-CoV-2 genomes and to determine the proportion of the number of genomes on the total number of reported COVID-19 cases (genome sampling) of a given country during the study period (until is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10. 1101 rmed_global.csv) and the number of genomes from GISAID (by August 8, 2020). Only the genomes with collection date until March 31, 2020 were considered. When a given genome only indicated the month of collection, but not the day, it was added to the sum of the last day of the respective month. When the number of genomes on a given day was higher than the number of cases, the number of cases was considered for graphical representation. Final data on the assessment of genome sampling by country is provided in Supplementary material (Table S2) .

For the phylogenetic analyses, we downloaded full-length viral genome sequences from GISAID (https://www.gisaid.org/) on August 6, 2020 with collection dates before April 1, 2020 (Table S2) . For computational efficiency in the downstream operations, we analysed the A and B lineages seperately. Multiple sequence alignments with a reference genome (MN908947.3) were performed using MAFFT v7.458 with parameter --addfragments (Katoh et al, 2009) . Sequences with fewer than 75% unambiguous bases were excluded, as well as duplicate sequences defined as having identical nucleotide composition, collected on the same date and in the same country. The resulting dataset was trimmed at the 5' and 3' ends resulting in a multi-sequence alignment with 29780 nucleotides. Sequences with date information at the year-level were also excluded. This dataset was subjected to multiple iterations of phylogeny reconstruction using IQ-TREE multicore software version 1.6.12 (Nguyen et al, 2015) with parameters -m GTR+G, and exclusion of outlier sequences whose genetic divergence and sampling date were incongruent using TempEst software version 1.5.2 (Rambaut et al, 2016) , resulting in 1632 and 22124 sequences for the A and B datasets, respectively. GISAID acknowledgment table for the background dataset is provided as Supplementary Material (Table S3) .

The magnitude of the B datasets prohibits a full Bayesian inference approach in a reasonable timeframe. To overcome this constraint, we used a subsampling strategy that removes sequences such that monophyletic clusters that consist entirely of sequences from a particular country are represented by a single sequence. The excess sequences in a countryspecific monophyletic clade do not contribute any additional information to the betweencountry diffusion process we aim to infer (Hong et al, 2020) . This process resulted in a . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252216 doi: medRxiv preprint dataset with 13489 sequences (B_CS). Despite the almost 40% downsampling in the B lineage dataset, its size is still excessive for timely computational inferences. To further address this, we have built a phylogeny using IQ-TREE, as described previously, and partitioned the tree in 6 monophyletic clades (B_CS1 through B_CS6). These clades were examined for outlier sequences whose genetic divergence and sampling date were incongruent using TempEst software version 1.5.2 (Rambaut et al, 2016) .

A total of 1275 SARS-CoV-2 genome sequences (obtained from positive samples collected until March 31 st , 2020) from Portugal were analyzed in this study (INSA's collection, as of July 23 rd , 2020; Table S1 ). Our interest lies in estimating the viral evolutionary history and spatial diffusion process of the early epidemics in the country. Travel history data is of particular importance when analyzing low diversity data, such as that for SARS-CoV-2, using Bayesian joint inference of sequence and location traits because sharing the same location state can contribute to the phylogenetic clustering of taxa (Lemey et al, 2020) . For each of the datasets (A, and B_CS1 through B_CS6), we performed a joint genealogical and phylogeographic inference of time-measured trees using Markov chain Monte Carlo (MCMC) sampling implemented in the Bayesian Evolutionary Analysis Sampling Trees (BEAST) package . We applied a Hasegawa-Kishino-Yano 85 (HKY85) (Hasegawa et al, 1985) substitution model with gamma-distributed rate variation among sites (Shapiro et al, 2006) . We used an uncorrelated lognormal relaxed molecular clock to account for evolutionary rate variation among lineages and specified an exponential growth coalescent prior in our analyses.

To integrate the travel history information obtained from (returning) travelers, we followed Lemey et al. (2020) (Lemey et al, 2020) and augmented the phylogeny with ancestral nodes that are associated with a location state (but not with a known sequence), and enforced the ancestral location at a point in the past of a lineage. We specified normal prior distributions on the travel times informed by an estimate of time of infection and truncated to be positive (back-in-time) relative to sampling date. Specifically, we use a period of 14 days (incubation period of 99% of patients (Lauer et al, 2020) where travel history information was collected for all recent movements, and a period between symptom onset and testing with an estimated mean of 4.70 days for the patients in the INSA cohort, and a standard deviation of 4.06 days to incorporate the uncertainty on the period between symptom onset and testing. The location traits associated with taxa and with the ancestral nodes were modeled using a bidirectional . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252216 doi: medRxiv preprint asymmetric discrete diffusion process (Lemey et al, 2009) . We ran and combined at least eight independent MCMC analyses for 50 million generations, sampling every 50000th generation and removed 10% as chain burn-in. Stationarity and mixing was investigated using Tracer software version 1.7.1 , making sure that effective sample sizes for the continuous parameters were greater than 100. We used the high-performance computational capabilities of the Biowulf cluster at the National Institutes of Health (Bethesda, MD, USA) (http://biowulf.nih.gov) to perform these analyses. Portuguese clusters were assumed for phylogeographic summaries if their topology posterior probability was equal or higher than 0.001. If the excluded genomes had known travel history, they were re-integrated along with same-cluster sequences if those did not cluster in a clade-defining polytomy (recovered a total of 14 sequences, 7 of them with travel history).

A website (https://insaflu.insa.pt/covid19) was launched on March 28, 2020 for real-time data sharing on SARS-CoV-2 genetic diversity and geotemporal spread in Portugal. This site gives access to "situation reports of the study and provides interactive data navigation using both 

SARS-CoV-2 genome sequences generated in this study were uploaded to the GISAID database (https://www.gisaid.org/). Accession numbers can be found in Supplementary material (Table S1) .

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The first COVID-19 confirmed cases in Portugal were reported on March 2, 2020 after is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint (Borges et al, 2020) . For the sake of graphical simplicity, the trajectory of the cov-lineages is shown as genome count instead of relative frequency. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252216 doi: medRxiv preprint Pango lineages are colored according to the corresponding GISAID clades (when 100% congruence). For incongruent cases (labeled by an asterisk), the color reflects the most abundant GISAID clade within a given Pango lineage. The dashed line in the Nextstrain classification panel reflects the cumulative number of COVID-19 confirmed cases as shown in Figure   1 . The map shows the relative frequency of Nextstrain clades by Health Administration region (circles are proportional to the number of confirmed cases by region) in March 2020. Classification is detailed in 

In order to assess the origins and measure the number of SARS-CoV-2 introductions in Portugal prior March 31, 2020, we performed Bayesian phylodynamic analyses integrating the rich travel history data. Travel history could be collected for 619 (48.5%) out of 1275 confirmed cases detected in March, with 128 (10.0%) reporting international travels within the potential incubation period (i.e. 14 days before clinical onset date) and 491 (38.5%) reporting no travels within the same period ( Figure 3A) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 have received approximately 30% of all introductions, followed by the North (27%), Center (10%), Algarve (4 %), Azores (2%), Alentejo (2%) and Madeira (1%) regions (Figure 5 and   6A ; Table S4 ). We also examined the number of infections generated by introductions from different countries (Figure 5 and 6B; Table S5 ). Interestingly, despite the UK, France and Spain having seeded the majority of introductions, at least one seeding event with travel history from Italy generated the largest outbreak recorded in early stages of the COVID-19 epidemic in Portugal (cfr. below) (Borges et al, 2020) . We noticed a similar pattern for an introduction from Thailand, however this event had a low supported topology posterior probability ( Figure   5 and 6B; Table S5 ).

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table S5 . For both panels, for graphics simplicity, we present the eleven countries linked with most introductions (left) and relative number of infections generated (right), estimated across phylogenies inferred for the whole dataset, i.e., including both Pango lineages A and B (thinlow proportion of number/size of viral introductions attributed to this source; thickhigh proportion of number/size of viral introductions attributed to this source). We note that there is no temporal order for the transitions involved. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 time to the most recent common ancestor (tMRCA in blue). C. Violin plot and point density depict the time lag between the introduction and the first surveilled genome.

The present study provides a comprehensive description of the early establishment of the COVID-19 pandemic in Portugal. We detected multiple independent SARS-CoV-2 introductions, mostly from European countries (namely the UK, Spain, France, Italy and Switzerland), which was broadly consistent with the available travel history data, as well as with the countries with most frequent flight connectivity (INE, 2020) and/or with the highest number of Portuguese immigrants (UN, 2019) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 countries from different latitudes (especially from Europe, South America and Africa). Phylodynamic modeling relies on the accumulation of genetic diversity over time for estimation of the evolutionary rate and timing of other relevant events. Being a recently emerged pathogen with a lower substitution rate (in comparison with other RNA viruses) and a large genome, it is challenging to study the early dynamics of SARS-CoV-2, as a large proportion of sequences collected across time and space are very closely related genetically, thus complicating the reconstruction of the phylogenetic topology. To address this, we opted to focus on a subset of the results with higher topological support. Furthermore, due to the computational burden required for phylodynamic analysis, it is unfeasible to include all available genomic sequences. One limitation of this and other studies trying to infer the origin of introductions is the sequencing sampling bias by country. For this reason, we resorted to filtering and subsampling strategies that aim at reducing the number of genomes that do not significantly contribute to the evolutionary or phylogeographic reconstructions. Despite being less pronounced, there were still discrepancies in the number of genomes included across countries. For instance, it is very likely that the number of introductions via the UK (the country . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10. 1101 generating the highest volume of sequences) is overestimated, while the number of introductions from countries with none or few available genome sequences is underestimated. However, the integration of travel history during the phylodynamic inferences allows for a more accurate reconstruction of the spatial pathways from both over and undersampled locations. Additionally, using this recently developed model provides insight into the genetic diversity circulating in countries for which genomic surveillance is still lacking.

This makes the present work among the first to apply this novel model, which allowed us to gain insight into the early circulating diversity in countries like Saint Thomas and Prince, for which (as of February 15, 2021) there are no sequences available, and other undersampled countries such as the United Arabe Emirates and Qatar.

Overall, our findings highlight the use of genomic data to trace the introduction and spread of an emerging virus, showing the need of systematic, continuous and geographically representative genomic surveillance to detect and monitor the emergence and dissemination of biologically and/or epidemiologically relevant variants. Together with open data sharing, the timely generation of SARS-CoV-2 genomic data has been shown to be an invaluable tool to guide national and international public health authorities towards the identification and control of highly transmissible and/or immune evading variants (ECDC, 2021) .

In this context, by laying the foundation of the genomic epidemiology of SARS-CoV-2 in Portugal, involving an unprecedented collaborative effort at national and international levels, this work, and subsequent capacity building, was pivotal for Portugal to respond to the current and upcoming needs of a genomic-informed surveillance and epidemiology of COVID-19, as strongly recommended by ECDC and WHO (WHO, 2021; ECDC, 2021).

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

This study was approved by the Ethical Committee ("Comissão de Ética para a Saúde") of the Portuguese National Institute of Health. Designations of all genome sequences are fully anonymized, and no identifying information of the associated patients is provided.

We gratefully acknowledge to Sara Hill and Nuno Faria (University of Oxford) and Joshua Quick and Nick Loman (University of Birmingham) for kindly providing us with the initial sets of Artic Network primers for NGS; Rafael Mamede (MRamirez team, IMM, Lisbon) for developing and sharing a bioinformatics script for sequence curation (https://github.com/rfm-. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252216 doi: medRxiv preprint targa/BioinfUtils); Philippe Lemey (KU Leuven) for providing guidance on the implementation of the phylodynamic models; Joshua L. Cherry (National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health) for providing guidance with the subsampling strategies; and all authors, originating and submitting laboratories who have contributed genome data on GISAID (https://www.gisaid.org/) on which part of this research is based. The opinions expressed in this article are those of the authors and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.

No conflicts of interest were declared.

This study is co-funded by Fundação para a Ciência e Tecnologia and Agência de Investigação Clínica e Inovação Biomédica (234_596874175) on behalf of the Research 4 COVID-19 call. Some infrastructural resources used in this study come from the GenomePT project (POCI-01-0145-FEDER-022184), supported by COMPETE 2020 -Operational Programme for Competitiveness and Internationalisation (POCI), Lisboa Portugal Regional Operational Programme (Lisboa2020), Algarve Portugal Regional Operational Programme (CRESC Algarve2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), and by Fundação para a Ciência e a Tecnologia (FCT).

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region

Microreact: visualizing and sharing data for genomic epidemiology and phylogeography

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal

INSaFLU: an automated open web-based bioinformatics suite "from-reads" for influenza whole-genome-sequencing-based surveillance

An interactive web-based dashboard to track COVID-19 in real time

Relaxed phylogenetics and dating with confidence

COVID-19 Genomics UK (COG-UK) Consortium, Aanensen DM, Kraemer MUG, Rambaut A, Pybus OG. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science

European Centre for Disease Prevention and Control. Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA -29

Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States

Introductions and early spread of SARS-CoV-2 in France

Nextstrain: real-time tracking of pathogen evolution

Dating of the human-ape splitting by a molecular clock of mitochondrial DNA

Search of Covariates of HIV

Subtype B Spread in the United States-A Cautionary Tale of Large-Scale Bayesian Phylogeography

Multiple alignment of DNA sequences with MAFFT

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2

Bayesian phylogeography finds its roots

Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events

The origin and early spread of SARS-CoV-2 in Europe

IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Posterior Summarization in

Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Choosing appropriate substitution models for the phylogenetic analysis of proteincoding sequences

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

portuguesas-World Health Organization (WHO) Coronavirus disease (COVID-19) Situation

Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health

Author Correction: A new coronavirus associated with human respiratory disease in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin